A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called Mylotarg) for the potential treatment of acute myeloid leukemia (AML). AML is a disease that affects the body's white blood cells. This study is seeking participants in Korea who: * Are 18 years of age or older * Are adults and newly diagnosed with AML * Currently receive Mylotarg for AML treatment in a hospital * Are capable of a personally signed and dated informed consent document indicating that the participant (or a legally acceptable representative) has been informed of all pertinent aspects of the study. Participant's health will be closely monitored for any unwanted reactions during Mylotarg treatment. Disease progression will also be monitored. This will help determine if Mylotarg is safe to use and its effect on AML treatment.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Niedawno rozpoznana ostra białaczka szpikowa (AML) z markerem CD33
- •Pacjent leczony lub mający być leczony lekiem Mylotarg w warunkach szpitalnych
- •Świadoma zgoda na uczestnictwo w badaniu (podpisana i datowana)
✗ Disqualifies
- •Uczulenie lub alergia na składniki leku Mylotarg, w tym ciężkie reakcje alergiczne
- •Brak zgody na udostępnianie swoich informacji medycznych firmie Pfizer i jej partnerom
Simplified criteria — AI translation
Trial details
- Minimum age
- 19 Years
- Last updated (source)
- July 24, 2026
- Sex
- No restrictions
Locations (1)
Seoul national university hospital
Seoul, South Korea
Trial contact
Pfizer CT.gov Call Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.